169 related articles for article (PubMed ID: 38561739)
41. H
Xiao Z; Zuo W; Chen L; Wu L; Liu N; Liu J; Jin Q; Zhao Y; Zhu X
ACS Appl Mater Interfaces; 2021 Sep; 13(37):43925-43936. PubMed ID: 34499485
[TBL] [Abstract][Full Text] [Related]
42. pH-Activatable copper-axitinib coordinated multifunctional nanoparticles for synergistic chemo-chemodynamic therapy against aggressive cancers.
Ji M; Liu H; Wang H; Liang X; Wei M; Shi D; Gou J; Yin T; He H; Tang X; Zhang Y
Biomater Sci; 2023 Sep; 11(18):6267-6279. PubMed ID: 37545202
[TBL] [Abstract][Full Text] [Related]
43. Blood-brain Barrier Permeable and Multi-stimuli Responsive Nanoplatform for Orthotopic Glioma Inhibition by Synergistic Enhanced Chemo-/Chemodynamic/Photothermal/Starvation Therapy.
Cao Y; Jin L; Zhang S; Lv Z; Yin N; Zhang H; Zhang T; Wang Y; Chen Y; Liu X; Zhao G
Eur J Pharm Sci; 2023 Jan; 180():106319. PubMed ID: 36328086
[TBL] [Abstract][Full Text] [Related]
44. Photothermal and ferroptosis synergistic therapy for liver cancer using iron-doped polydopamine nanozymes.
Li Y; Qian L; Yang Z; Li S; Wu A; Wang X
Colloids Surf B Biointerfaces; 2024 Jul; 239():113911. PubMed ID: 38714079
[TBL] [Abstract][Full Text] [Related]
45. Cu-Chelated polydopamine nanoparticles as a photothermal medium and "immunogenic cell death" inducer for combined tumor therapy.
Xu N; Hu A; Pu X; Wang J; Liao X; Huang Z; Yin G
J Mater Chem B; 2022 Apr; 10(16):3104-3118. PubMed ID: 35348176
[TBL] [Abstract][Full Text] [Related]
46. Intelligent responsive copper-diethyldithiocarbamate-based multifunctional nanomedicine for photothermal-augmented synergistic cancer therapy.
Meng X; Wu J; Hu Z; Zheng X
J Mater Chem B; 2024 Jan; 12(5):1285-1295. PubMed ID: 38189142
[TBL] [Abstract][Full Text] [Related]
47. Biomimetic Yolk-Shell Nanocatalysts for Activatable Dual-Modal-Image-Guided Triple-Augmented Chemodynamic Therapy of Cancer.
Pan Y; Zhu Y; Xu C; Pan C; Shi Y; Zou J; Li Y; Hu X; Zhou B; Zhao C; Gao Q; Zhang J; Wu A; Chen X; Li J
ACS Nano; 2022 Nov; 16(11):19038-19052. PubMed ID: 36315056
[TBL] [Abstract][Full Text] [Related]
48. Boosting Chemodynamic Therapy by the Synergistic Effect of Co-Catalyze and Photothermal Effect Triggered by the Second Near-Infrared Light.
Zhang S; Jin L; Liu J; Liu Y; Zhang T; Zhao Y; Yin N; Niu R; Li X; Xue D; Song S; Wang Y; Zhang H
Nanomicro Lett; 2020 Sep; 12(1):180. PubMed ID: 34138182
[TBL] [Abstract][Full Text] [Related]
49. Mitochondria-Targeting MoS
Li X; Xiao H; Xiu W; Yang K; Zhang Y; Yuwen L; Yang D; Weng L; Wang L
ACS Appl Mater Interfaces; 2021 Dec; 13(47):55928-55938. PubMed ID: 34786942
[TBL] [Abstract][Full Text] [Related]
50. Near-Infrared II Plasmonic Phototheranostics with Glutathione Depletion for Multimodal Imaging-Guided Hypoxia-Tolerant Chemodynamic-Photocatalytic-Photothermal Cancer Therapy Triggered by a Single Laser.
Shan B; Liu H; Li L; Lu Y; Li M
Small; 2022 Jan; 18(4):e2105638. PubMed ID: 34821041
[TBL] [Abstract][Full Text] [Related]
51. Hollow Porous Carbon Coated FeS
Wu F; Zhang Q; Zhang M; Sun B; She Z; Ge M; Lu T; Chu X; Wang Y; Wang J; Zhou N; Li A
ACS Appl Mater Interfaces; 2020 Mar; 12(9):10142-10155. PubMed ID: 32043350
[TBL] [Abstract][Full Text] [Related]
52. A biocompatible theranostic agent based on stable bismuth nanoparticles for X-ray computed tomography/magnetic resonance imaging-guided enhanced chemo/photothermal/chemodynamic therapy for tumours.
Zhao H; Wang J; Li X; Li Y; Li C; Wang X; Wang J; Guan S; Xu Y; Deng G; Chen Y; Lu J; Liu X
J Colloid Interface Sci; 2021 Dec; 604():80-90. PubMed ID: 34265694
[TBL] [Abstract][Full Text] [Related]
53. Recent Advances in Single Fe-Based Nanoagents for Photothermal-Chemodynamic Cancer Therapy.
Zhang L; Forgham H; Shen A; Qiao R; Guo B
Biosensors (Basel); 2022 Jan; 12(2):. PubMed ID: 35200346
[TBL] [Abstract][Full Text] [Related]
54. Near-Infrared Phototheranostic Iron Pyrite Nanocrystals Simultaneously Induce Dual Cell Death Pathways via Enhanced Fenton Reactions in Triple-Negative Breast Cancer.
Zhao C; Liu Z; Chang CC; Chen YC; Zhang Q; Zhang XD; Andreou C; Pang J; Liu ZX; Wang DY; Kircher MF; Yang J
ACS Nano; 2023 Mar; 17(5):4261-4278. PubMed ID: 36706095
[TBL] [Abstract][Full Text] [Related]
55. Highly Efficient GSH-Responsive "Off-On" NIR-II Fluorescent Fenton Nanocatalyst for Multimodal Imaging-Guided Photothermal/Chemodynamic Synergistic Cancer Therapy.
Li H; Liu Y; Huang B; Zhang C; Wang Z; She W; Liu Y; Jiang P
Anal Chem; 2022 Jul; 94(29):10470-10478. PubMed ID: 35816734
[TBL] [Abstract][Full Text] [Related]
56. An Activatable Phototheranostic Nanoplatform for Tumor Specific NIR-II Fluorescence Imaging and Synergistic NIR-II Photothermal-Chemodynamic Therapy.
Dai Y; Zhang F; Chen K; Sun Z; Wang Z; Xue Y; Li M; Fan Q; Shen Q; Zhao Q
Small; 2023 Jun; 19(22):e2206053. PubMed ID: 36852618
[TBL] [Abstract][Full Text] [Related]
57. Sulfur Defect-Engineered Biodegradable Cobalt Sulfide Quantum Dot-Driven Photothermal and Chemodynamic Anticancer Therapy.
Zhu H; Huang S; Ding M; Li Z; Li J; Wang S; Leong DT
ACS Appl Mater Interfaces; 2022 Jun; 14(22):25183-25196. PubMed ID: 35638599
[TBL] [Abstract][Full Text] [Related]
58. Engineering tumor-specific catalytic nanosystem for NIR-II photothermal-augmented and synergistic starvation/chemodynamic nanotherapy.
Zhou S; Xu J; Dai Y; Wei Y; Chen L; Feng W; Chen Y; Ni X
Biomater Res; 2022 Nov; 26(1):66. PubMed ID: 36435848
[TBL] [Abstract][Full Text] [Related]
59. Nanocatalytic theranostics with intracellular mutual promotion for ferroptosis and chemo-photothermal therapy.
Zhang M; Chen Y; Wang Q; Li C; Yuan C; Lu J; Luo Y; Liu X
J Colloid Interface Sci; 2024 Mar; 657():619-631. PubMed ID: 38071811
[TBL] [Abstract][Full Text] [Related]
60. Dumbbell-shaped bimetallic AuPd nanoenzymes for NIR-II cascade catalysis-photothermal synergistic therapy.
Tang Z; Hou Y; Huang S; Hosmane NS; Cui M; Li X; Suhail M; Zhang H; Ge J; Iqbal MZ; Kong X
Acta Biomater; 2024 Mar; 177():431-443. PubMed ID: 38307478
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
